Straumann Holding: Drug Development and Clinical Development – Six Business Analyses

Which Straumann product and solution areas should be compared for investment, maintenance, selective development or rationalisation?

A Straumann Holding BCG Matrix provides a disciplined way to review a portfolio through market growth and relative market share, rather than treating every dental offering as equally strategic. The framework uses the familiar Stars, Cash Cows, Question Marks and Dogs categories as analytical possibilities, not as assigned labels. For a business serving clinical professionals, the useful comparison may include implant-related solutions, biomaterials, digital workflows or adjacent service propositions, while considering each area's growth environment and competitive position.

• Portfolio logic. Compare categories according to relative market share and market growth, then identify where management attention or evidence gathering may be most valuable.
• Resource trade-offs. Consider whether clinical education, product development, manufacturing capacity or commercial support should be assessed differently across portfolio areas.
• Structured review. Use the Excel framework to organise candidate offerings and assumptions, then use the Word analysis to interpret the strategic questions behind each possible position.

What industry pressures shape the attractiveness and defensibility of the dental implant and clinical-solution environment?

Straumann Holding Porter's Five Forces analysis examines the structure surrounding dental professionals and the suppliers that support their treatment workflows. Rivalry can be considered in markets where clinical evidence, professional trust and product breadth matter. Supplier power may arise around specialised materials, manufacturing know-how or technology inputs; buyer power may reflect purchasing choices by practices, groups or distributors. The framework also tests the threat of new entrants and substitutes, including alternative ways of addressing a patient's restorative or dental-treatment need rather than only direct competing brands.

• Competitive pressure. Explore how differentiation through clinical support, product reliability and practitioner confidence may influence rivalry without assigning unsupported force scores.
• Switching dynamics. Assess questions around training, workflow integration, purchasing influence and alternatives that could affect buyer choice or substitution risk.
• Evidence trail. Record force-specific observations in the Excel structure and use the Word analysis to distinguish observed industry context from assumptions requiring validation.

Which external changes could alter the conditions under which a Swiss dental technology business develops, supplies and supports its solutions?

A Straumann Holding PESTLE analysis, also commonly called PESTEL, separates Political, Economic, Social, Technological, Legal and Environmental influences. Political and legal questions may include the policy and regulatory conditions relevant to dental and health-related products. Economic analysis can test purchasing conditions, healthcare spending pressures and cross-border operating exposure. Social factors include ageing populations, patient expectations and the importance of practitioner trust; technological factors include digital dentistry and material innovation. Environmental questions can examine manufacturing, sourcing and lifecycle expectations without asserting a particular current regulation or company outcome.

• External scan. Organise macro factors that may affect clinical adoption, professional demand, product access and the cost of operating across markets.
• Change signals. Separate documented external developments from policy, rate, technology or sustainability questions that need monitoring rather than assumptions.
• Scenario workspace. Use the Excel categories to compare possible external effects, while the Word analysis helps explain why each factor may matter to the business model.